Comparison of Software-assisted Implantation of Elastic Spine Pad (TM) With Respect to Postoperative Change in Neck Disability Index (NDI) With the Conventional Disc Spacer Squale (TM) After Anterior Cervical Discectomy for Cervical Disc Prolapse
NCT ID: NCT02936765
Last Updated: 2016-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
52 participants
INTERVENTIONAL
2016-06-30
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Software-assisted Implantation of Elastic Spine Pad (TM) With Respect to Postoperative Change in Neck Disability Index (NDI) With the Conventional Disc Prosthesis Rotaio (TM) After Anterior Cervical Discectomy for Cervical Disc Prolapse
NCT02936739
Evaluation on Efficacy of Total Artificial Disc Replacement (TDR) of Cervical Spondylosis
NCT03364816
Cervical Arthroplasty "Fixed Core" Versus "Movable Core": Clinical and Radiological Impact in the Medium Term
NCT02924506
LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDE
NCT00389597
Investigation of the Simplify® Cervical Artificial Disc
NCT02667067
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elastic spine pad
Patients, who receive Elastic Spine Pad (TM) as cervical disc prosthesis after ventral discectomy.
Anterior cervical discectomy with prosthetic disc replacement / ESP.
Anterior cervical discectomy, with the use of the ESP prosthesis (Manufacturer: FH orthopedics, Mulhouse, France) for the disc replacement.
Squale
Patients, who receive Squale (TM) as cervical disc prosthesis after ventral discectomy.
Anterior cervical discectomy with prosthetic disc replacement / Squale.
Anterior cervical discectomy, with the use of the Squale spacer (Manufacturer: OSD, Avignon, France) for the disc replacement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anterior cervical discectomy with prosthetic disc replacement / ESP.
Anterior cervical discectomy, with the use of the ESP prosthesis (Manufacturer: FH orthopedics, Mulhouse, France) for the disc replacement.
Anterior cervical discectomy with prosthetic disc replacement / Squale.
Anterior cervical discectomy, with the use of the Squale spacer (Manufacturer: OSD, Avignon, France) for the disc replacement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Necessity of implantation of a device smaller in height than 5 mm (as predicted with teh use of the Vertaplan (TM) software
* Transversal spine cord lesion
* Cervical myelopathy
* Preceding surgery on the cervical spine
* Traumatic lesions of the cervical spine
* Radiographic instability in the affected segment: flexion / extension: shift sagittal plane\> 3.5 mm or 20% and rotation in the sagittal plane \> 20 °, OR in static X-ray examinations: shift in the sagittal plane 3.5 mm or 20% of the vertebral body width and relative sagittal plane angulation \> 11º
* signs of instability (Olisthesis) in another segment of the cervical spine
* Active systemic infection
* diseases of the rheumatic type and all autoimmune diseases
* bone metabolic diseases (for example, Paget's disease)
* skeletal metastases
* infections in the cervical spine
* Neurological seizure disorders or other serious neurological disease with risk of falls
* Severe heart failure (NYHA III-IV)
* Bleeding disorders or clopidogrel / coumarins - treatment
* Systemic use of corticosteroids for more than a month in the last 12 months
* Pregnancy
* Legally incompetent patient
* Lactation
* Deformity, anomalies, not fully developed skeleton
* Local tumor disease
* Pre-existing neurologic abnormalities or other shortcomings, such as a Parkinson's disease, diabetic neuropathy, multiple sclerosis, peripheral neuropathy
* Drug / drug or alcohol dependence
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uniklinikum Dresden
Dresden, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCH_ESPvsSquale
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.